1,026 results on '"BRANDER, CHRISTIAN"'
Search Results
102. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load
103. Gradual adaptation of HIV to human host populations: good or bad news?
104. HIV Molecular Immunology 2015
105. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA
106. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus
107. Cytotoxic HIV-1 p55gag-Specific CD4+ T Cells Produce HIV-Inhibitory Cytokines and Chemokines
108. Nef interference with HIV-1–specific CTL antiviral activity is epitope specific
109. T-Follicular-Like CD8+ T Cell Responses in Chronic HIV Infection Are Associated With Virus Control and Antibody Isotype Switching to IgG.
110. Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef
111. The leukotriene B4 lipid chemoattractant receptor BLT1 defines antigen-primed T cells in humans
112. The challenges of host and viral diversity in HIV vaccine design
113. Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes
114. HIV-specific CD8 T cells express low levels of IL-7Rα: Implications for HIV-specific T cell memory
115. Does Antigen Glycosylation Impact the HIV-Specific T Cell Immunity?
116. Evolution and transmission of stable CTL escape mutations in HIV infection
117. Dominant Epstein–Barr virus-specific T-cell responses are maintained during moderate and intense immunosuppressive treatment
118. Pharmacokinetic/pharmacodynamic analysis of romidepsin used as an HIV latency reversing agent
119. Priming with Recombinant BCG Expressing HTI Enhances the Magnitude and Breadth of the T-Cell Immune Responses Elicited by MVA.HTI in BALB/c Mice
120. Immune Profiles Identification by Vaccinomics After MVA Immunization in Randomized Clinical Study
121. Abstract 929: Transcriptomic analysis of pre-treatment tissue samples to predict clinical benefit to durvalumab in HIV-infected cancer patients
122. Methylation regulation of Antiviral host factors, Interferon Stimulated Genes (ISGs) and T-cell responses associated with natural HIV control
123. SARS-CoV-2 Consensus-Sequence and Matching Overlapping Peptides Design for COVID19 Immune Studies and Vaccine Development
124. The Genome-wide Methylation Profile of CD4+ T Cells From Individuals With Human Immunodeficiency Virus (HIV) Identifies Distinct Patterns Associated With Disease Progression
125. B-Cell Gene Expression and Microbiota Prior Immunization Profile Vaccine Humoral Responsiveness
126. TOX is expressed by exhausted and polyfunctional human effector memory CD8 + T cells
127. In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction
128. Specificity of CD8+ T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya
129. HIV-1 DNA decay dynamics in early treated individuals: practical considerations for clinical trial design
130. Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: Insights on the origin of the “Kaposiʼs sarcoma belt”
131. Cellular immune responses and disease control in acute AIDS-associated Kaposiʼs sarcoma
132. Profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage and antigen exposure
133. Adaptation of HIV-1 to human leukocyte antigen class I
134. Corrigendum to 'Therapeutic vaccination refocuses T-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study)' EClinicalMedicine 11 (2019) 65-80
135. The genome-wide methylation profile of CD4+ T cells from HIV-infected individuals identifies distinct patterns associated with disease progression
136. HIV Molecular Immunology 2014
137. Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection
138. Sustained and Focused Hepatitis B Virus Nucleocapsid–Specific T-Cell Immunity in Liver Transplant Recipients Compared To Individuals With Chronic and Self-Limited Hepatitis B Virus Infection
139. Increased detection of HIV-specific T cell responses by combination of central sequences with comparable immunogenicity
140. Recombinant BCG Expressing HTI Prime and Recombinant ChAdOx1 Boost Is Safe and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice
141. Human leukocyte antigen–associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution
142. Kaposiʼs sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposiʼs sarcoma
143. T cell receptor cross-recognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamily
144. TOX is expressed by exhausted and polyfunctional human effector memory CD8(+) T cells
145. Immune Profiles Identification by Vaccinomics After MVA Immunization in Randomized Clinical Study
146. IL-8 responsiveness defines a subset of CD8 T cells poised to kill
147. High degree of inter-clade cross-reactivity of HIV-1-specific T cell responses at the single peptide level
148. Differential immunogenicity of HIV-1 clade C proteins in eliciting CD[8.sup.+] and CD[4.sup.+] cell responses
149. An HLA-I signature favouring KIR-educated Natural Killer cells mediates immune control of HIV in children and contrasts with the HLA-B-restricted CD8+ T-cell-mediated immune control in adults.
150. Impact of intrapeptide epitope location on CD8 T cell recognition: implications for design of overlapping peptide panels
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.